{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T01:48:56Z","timestamp":1781920136249,"version":"3.54.5"},"reference-count":27,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fonds d\u2019Investissement de la Recherche Scientifique"}],"content-domain":{"domain":["burnsjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Burns"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.burns.2014.01.027","type":"journal-article","created":{"date-parts":[[2014,4,13]],"date-time":"2014-04-13T14:15:36Z","timestamp":1397398536000},"page":"1707-1712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Effect of N-acetylcysteine combined with infliximab on toxic epidermal necrolysis. A proof-of-concept study"],"prefix":"10.1016","volume":"40","author":[{"given":"Philippe","family":"Paquet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0062-2857","authenticated-orcid":false,"given":"Serge","family":"Jennes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Fran\u00e7oise","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Libon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Delvenne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rald E.","family":"Pi\u00e9rard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.burns.2014.01.027_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1517\/14656566.2010.512915","article-title":"Facing up to toxic epidermal necrolysis","volume":"11","author":"Pi\u00e9rard","year":"2010","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.burns.2014.01.027_bib0010","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2174\/157488612805076516","article-title":"Toxic epidermal necrolysis","volume":"7","author":"Castelain","year":"2012","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.burns.2014.01.027_bib0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2165\/11532540-000000000-00000","article-title":"New insights in toxic epidermal necrolysis (Lyell's syndrome). Clinical considerations, pathobiology and targeted treatments revisited","volume":"33","author":"Paquet","year":"2010","journal-title":"Drug Saf"},{"key":"10.1016\/j.burns.2014.01.027_bib0020","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1600-0560.1999.tb01848.x","article-title":"Epidermal calprotectin in drug-induced toxic epidermal necrolysis","volume":"26","author":"Paquet","year":"1999","journal-title":"J Cutan Pathol"},{"key":"10.1016\/j.burns.2014.01.027_bib0025","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000097652","article-title":"Glutathione-S-transferase pi expression in toxic epidermal necrolysis: a marker of putative oxidative stress in keratinocytes","volume":"20","author":"Paquet","year":"2007","journal-title":"Skin Pharmacol Physiol"},{"key":"10.1016\/j.burns.2014.01.027_bib0030","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2174\/157488612805076570","article-title":"Deciphering supportive treatment strategies for toxic epidermal necrolysis","volume":"7","author":"Jennes","year":"2012","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.burns.2014.01.027_bib0035","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1365-2133.2002.46833.x","article-title":"Antitumour necrosis factor-\u03b1 antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis","volume":"146","author":"Fischer","year":"2002","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.burns.2014.01.027_bib0040","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1080\/00015550510037062","article-title":"Toxic epidermal necrolysis associated with high intake of sildenafil and its response to infliximab","volume":"85","author":"Al-Shouli","year":"2005","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.burns.2014.01.027_bib0045","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1016\/j.jaci.2005.06.029","article-title":"Rapid resolution of toxic epidermal necrolysis with anti-TNF-\u03b1 treatment","volume":"116","author":"Hunger","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.burns.2014.01.027_bib0050","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1468-3083.2006.02026.x","article-title":"Overlap of acute generalized exanthematous pustulosis and toxic epidermal necrolysis: response to antitumour necrosis factor-alpha antibody infliximab: report of three cases","volume":"21","author":"Meiss","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.burns.2014.01.027_bib0055","doi-asserted-by":"crossref","first-page":"420","DOI":"10.2340\/00015555-0462","article-title":"Beneficial and rapid effect of infliximab on the course of toxic epidermal necrolysis","volume":"88","author":"Wojtkiewicz","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.burns.2014.01.027_bib0060","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1346-8138.2010.00893.x","article-title":"Etoricoxib-induced toxic epidermal necrolysis: successful treatment with infliximab","volume":"37","author":"Kreft","year":"2010","journal-title":"J Dermatol"},{"key":"10.1016\/j.burns.2014.01.027_bib0065","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/j.1365-2230.2012.04357.x","article-title":"Reaction to biological drugs: infliximab for the treatment of toxic epidermal necrolysis subsequently triggering erosive lichen planus","volume":"37","author":"Worsnop","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.burns.2014.01.027_bib0070","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000338202","article-title":"Treatment of toxic epidermal necrolysis with the combination of infliximab and high-dose intravenous immunoglobulin","volume":"224","author":"Gaitanis","year":"2012","journal-title":"Dermatology"},{"key":"10.1016\/j.burns.2014.01.027_bib0075","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1345\/aph.1K001","article-title":"Etanercept for toxic epidermal necrolysis","volume":"41","author":"Famularo","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.burns.2014.01.027_bib0080","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1111\/j.1346-8138.2009.00616.x","article-title":"Toxic epidermal necrolysis successfully treated with etanercept","volume":"36","author":"Gubinelli","year":"2009","journal-title":"J Dermatol"},{"key":"10.1016\/j.burns.2014.01.027_bib0085","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/j.1365-4632.2008.04020.x","article-title":"Etanercept in the treatment of a patient with acute generalized exanthematous pustulosis\/toxic epidermal necrolysis: definition of a new model based on translational research","volume":"48","author":"Sadighha","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.burns.2014.01.027_bib0090","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.1365-2133.1997.tb02175.x","article-title":"Drug-induced hypersensitivity syndrome and toxic epidermal necrolysis. Treatment with N-acetylcysteine","volume":"136","author":"Redondo","year":"1997","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.burns.2014.01.027_bib0095","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1067\/mjd.2002.118557","article-title":"Toxic epidermal necrolysis treated with N-acetylcysteine","volume":"46","author":"V\u00e9lez","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.burns.2014.01.027_bib0100","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1517\/14712598.2010.500283","article-title":"The therapeutic potential of TNF-\u03b1 antagonists for skin psoriasis comorbidities","volume":"10","author":"Pi\u00e9rard","year":"2010","journal-title":"Exp Opin Biol Ther"},{"key":"10.1016\/j.burns.2014.01.027_bib0105","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/archderm.1993.01680220104023","article-title":"Clinical classification of cases of toxic epidermal necrolysis, Stevens\u2013Johnson syndrome, and erythema multiforme","volume":"129","author":"Bastuji-Garin","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.burns.2014.01.027_bib0110","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/clpt.2009.252","article-title":"ALDEN, an algorithm for assessment of drug causality in Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a comparison with case\u2013control analysis","volume":"88","author":"Sassolas","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.burns.2014.01.027_bib0115","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/BCR.0b013e31820aafbc","article-title":"Evaluation of SCORTEN on a cohort of patients with Stevens\u2013Johnson syndrome and toxic epidermal necrolysis included in the RegiSCAR study","volume":"32","author":"Sekula","year":"2011","journal-title":"J Burn Care Res"},{"key":"10.1016\/j.burns.2014.01.027_bib0120","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1097\/00000372-200010000-00005","article-title":"Immunoregulatory effector cells in drug-induced toxic epidermal necrolysis","volume":"22","author":"Paquet","year":"2000","journal-title":"Am J Dermatopathol"},{"key":"10.1016\/j.burns.2014.01.027_bib0125","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaad.2007.08.039","article-title":"Effects of treatments on the mortality of Stevens\u2013Johnson syndrome and toxic epidermal necrolysis: a retrospective study on patients included in the prospective EuroSCAR Study","volume":"58","author":"Schneck","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.burns.2014.01.027_bib0130","doi-asserted-by":"crossref","first-page":"352","DOI":"10.2174\/157488612805076507","article-title":"Drug interactions with normal and TEN epidermal keratinocytes","volume":"7","author":"Paquet","year":"2012","journal-title":"Curr Drug Saf"},{"key":"10.1016\/j.burns.2014.01.027_bib0135","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/jid.2012.330","article-title":"TNF-\u03b1 and IFN-\u03b3 are potential inducers of Fas-mediated keratinocyte apoptosis through activation of inducible nitric oxide synthase in toxic epidermal necrolysis","volume":"133","author":"Viard-Leveugle","year":"2013","journal-title":"J Invest Dermatol"}],"container-title":["Burns"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417914000606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0305417914000606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,25]],"date-time":"2024-05-25T21:49:11Z","timestamp":1716673751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0305417914000606"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":27,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0305417914000606"],"URL":"https:\/\/doi.org\/10.1016\/j.burns.2014.01.027","relation":{},"ISSN":["0305-4179"],"issn-type":[{"value":"0305-4179","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of N-acetylcysteine combined with infliximab on toxic epidermal necrolysis. A proof-of-concept study","name":"articletitle","label":"Article Title"},{"value":"Burns","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.burns.2014.01.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd and ISBI. All rights reserved.","name":"copyright","label":"Copyright"}]}}